Global Gonorrhea Treatment Market Opportunities And Forecast Analysis Up To 2026 | MELINTA THERAPEUTICS, INC, Alopexx Vaccine LLC, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Ltd, LUPIN

Gonorrhea treatment market is expected to grow at a substantial CAGR in the forecast period of 2019-2026. Emergence of drugs used to treat risk associated with gonorrhea and high demand of disease specific novel therapies are the key factors that fueling the market growth.

Download Sample PDF Copy of Report

Few of the major competitors currently working in the global gonorrhea treatment market are GlaxoSmithKline plc, MELINTA THERAPEUTICS, INC, Alopexx Vaccine LLC, AstraZeneca, Novartis AG, Teva Pharmaceutical Industries Ltd, LUPIN, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma, Mylan N.V., Hikma Pharmaceuticals PLC, WOCKHARDT, Nostrum Laboratories Inc, Mayne Pharma Group Limited, Apotex Inc, Pfizer Inc, Genocea Biosciences, Inc and others

In-depth analysis of the market

  1. Strategic recommendations in key business sections in light of the market estimations.
  2. Market share and size of all the foremost industry players.
  3. The key findings and recommendations highlight crucial progressive industry trends in the Gonorrhea Treatment Market, thereby allowing players to develop effective long term strategies
  4. To analyze opportunities in the market for stakeholders by identifying the high-growth segments of the Gonorrhea Treatment market
  5. Extensive analysis of the key segments of the industry helps in understanding the trends in types of Gonorrhea Treatment across Global.

Points Involved in Gonorrhea Treatment Market Report:

  • Gonorrhea Treatment Study Coverage
  • Executive Summary
  • Market Size by Application
  • Manufacturers Profiles
  • Production Forecasts
  • Consumption Forecast
  • Market Size by Manufacturers
  • Production by Regions
  • Consumption by Regions
  • Market Size by Type
  • Value Chain and Sales Channels Analysis
  • Gonorrhea Treatment Market Opportunities & Challenges, Risks and Influences Factors Analysis
  • Key Findings

Get Full Table Of content @

Key Developments in the Market:

  • In October 2017, Alopexx Vaccine LLC has completed the phase I clinical trial with AV0328, a vaccine targeting poly-N-acetyl glucosamine (PNAG) for the protection against many serious and life-threatening infections such as pneumonia, meningitis, bloodstream infections, and gonorrhea. In phase I clinical trial, AV0328 demonstrated excellent well-tolerated and safe which had no overall adverse event. If trial successful it will change treatment paradigms and improve the millions of people suffering from gonorrhea.
  • In June 2017, MELINTA THERAPEUTICS, INC, reported positive result of RX-P2177, a novel pyrrolocytosine antibiotic is developing for the treatment of gonorrhea. The trial demonstrated the strong activity in vitro against contemporary clinical gonorrhea isolates, including those resistant to ceftriaxone, ciprofloxacin and azithromycin. This clinical trial results indicating potentially significant clinical benefits for patients with gonorrhea.

Segmentation: Global Gonorrhea Treatment Market

Global Gonorrhea Treatment Market By Drug Class (Sulfonamides, Tetracycline, Aminopenicillins, Macrolides), Drugs (Erythromycin, Clarithromycin, Azithromycin, Roxithromycin and Others), Route of Administration (Oral, Injectable), End- Users (Hospitals, Homecare, Specialty Clinics, Others), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026

Market Drivers

  • Rising prevalence of the gonorrhea worldwide is driving the growth of this market
  • Huge financial support to the researchers for developing novel intervention is boosting the market growth
  • High demand of disease specific novel treatment can also act as a market driver
  • Increase in incidence of unprotected sex has led to an increase in the prevalence gonorrhea can propel the growth of this market

Market Restraints

  • Limited operating revenue opportunities for research and development of targeted therapies by many pharmaceuticals is acting as a challenging factor for the growth of this market
  • Low healthcare budget in some developing countries is hamper the market growth

Inquire Regarding This Report

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge Market Research provides appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. Get Customization and Discount on Report by emailing . We are content with our glorious 99.9 % client satisfying rate.


Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475

Back to top button